Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Irbesartan tablets bulk supplier for pharma manufacturers

Irbesartan Tablets 75 mg, 150 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 75 mg, 150 mg, 300 mg

Reference Brands: Avapro(Us & EU)

Category: Hypertension

Irbesartan tablets 75 mg, 150 mg and 300 mg, an angiotensin II receptor blocker for hypertension and diabetic kidney disease. For importers, distributors, hospitals and tender buyers needing registered generic supply.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Irbesartan Tablets? List it or send an offer →

Product Description:

Irbesartan is an angiotensin II receptor blocker, often called an ARB or sartan. It blocks the AT1 receptor, so angiotensin II can no longer constrict blood vessels or drive aldosterone release. Unlike ACE inhibitors it does not raise bradykinin, so dry cough is uncommon. This page covers 75 mg, 150 mg and 300 mg tablets. Its long action allows one dose a day.

Irbesartan is used for essential hypertension in adults and for kidney disease in hypertensive patients with type 2 diabetes. The usual dose is 150 mg once a day, taken with or without food, increased to 300 mg if needed. Like other drugs acting on the renin-angiotensin system it is avoided in pregnancy. Dual blockade with an ACE inhibitor or with aliskiren is generally avoided. Potassium and creatinine are monitored, particularly with potassium supplements, potassium-sparing diuretics or NSAIDs, and lithium levels can rise.

Sourcing notes. Irbesartan is prescription-only. Since nitrosamine impurities were found in several sartans, regulators expect a nitrosamine risk assessment for both API and tablets, with testing where a risk is identified, and some also ask about azido impurities. Ask for these with a CTD or ACTD dossier, bioequivalence data and Zone IVb stability for hot, humid markets. Blisters at room temperature are usual. Each batch should have a CoA covering related substances, and the file should include the GMP certificate and a CoPP. In your enquiry, give the strengths, pack size, quantity and target market.

Irbesartan Tablets — third party manufacturing & bulk supply

Irbesartan Tablets 75 mg, 150 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Irbesartan Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Irbesartan Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Irbesartan Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Irbesartan is used to treat high blood pressure (hypertension) and to protect the kidneys in patients with type 2 diabetes and hypertension. By blocking the action of angiotensin II, it helps relax blood vessels, improving blood flow and reducing the risk of heart attack, stroke, and kidney damage.

Irbesartan tablets are made from the active ingredient Irbesartan, which belongs to the class of angiotensin II receptor blockers (ARBs). The tablets may also contain inactive ingredients such as lactose, microcrystalline cellulose, croscarmellose sodium, povidone, and magnesium stearate, which help in tablet formulation and stability.

The common trade names of Irbesartan include Avapro®, Karvea®, Aprovel®, and Irovel®, which are available in various countries across the USA, UK, EU, and India.

Irbesartan is originally marketed by Sanofi-Aventis under the brand names Avapro®, Aprovel®, and Karvea®. It is also made by other manufacturers, including in India. We match each enquiry with licensed makers whose documents fit your market.

The generic name of the medicine is Irbesartan.

The brand names of Irbesartan include Avapro®, Karvea®, Aprovel®, and Irovel®.

It is made in several countries, including India. Tell us your market and we will match you with licensed makers whose documents fit.

Related Products

Captopril Tablet

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Capoten(US)

View Details
Azilsartan Tablets

Strength:
40 mg

Form: Tablets

Reference Brands: Edarbi (US/EU)

View Details
Nebivolol Tablets

Strength:
2.5 mg, 5 mg, and 10 mg

Form: Tablets

Reference Brands: Bystolic(US & EU)

View Details
Chlorthalidone Tablets

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: -

View Details
Rosuvastatin / Clopidogrel /Aspirin Capsules

Strength:
20 + 75 + 75 mg

Form: Capsules

Reference Brands: -

View Details
Atorvastatin / Clopidogrel / Aspirin Capsules

Strength:
20 + 75 + 75

Form: Capsules

Reference Brands: -

View Details
Valsartan Tablets

Strength:
40mg, 80 mg, 160 mg, 320 mg

Form: Tablets

Reference Brands: Diovan (USA/LATAM/ India)

View Details
Valsartan / Hydrochlorothiazide Tablets

Strength:
80 + 12.5 mg, 160 + 12.5 mg

Form: Tablets

Reference Brands: -

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us